Will potential Shein or Skims IPOs pan out in 2024? Several private companies are thinking about going public in 2024, including Chinese fast-fashion retailer Shein and Kim Kardashian’s SKIMS shapewear[Continue Reading]

Fear may cripple the development of AI in the short-term, says Toggle AI CEO Jan Szilagyi Jan Szilagyi, Toggle AI CEO, joins ‘Closing Bell: Overtime’ to discuss OpenAI and the[Continue Reading]

Markets are set up for a strong year-end rally, says Jay Woods Jay Woods, Chief Global Strategist at Freedom Capital Markets, discusses his expectations for the trading day ahead. Source:[Continue Reading]

Utility Stocks Are Coming Out of the Dark. 4 Companies to Consider. It took a while, but utility stocks are finally starting to pop. They still look appealing even after[Continue Reading]

Five potential takeover targets in the oil industry, following deals by Exxon Mobil and Chevron Five potential takeover targets in the oil industry, following deals by Exxon Mobil and Chevron[Continue Reading]

Gabelli Funds: How This Value Equity Firm Analyzes Opportunities Gabelli Funds is a pioneer in value equity, and the firm is recognized to have developed the Private Market Value with[Continue Reading]

Is ChatGPT writing your code? Watch out for malware Hackers have infiltrated a tool your software development teams may be using to write code. Not a comfortable place to be.[Continue Reading]

Give the Kids Their Inheritance Now or Make Them Wait? 3 Things to Keep in Mind. Are you better off giving money to children now when you can see the[Continue Reading]

Israel-Hamas War, Part 1: Implications for Aerospace & Defense ETFs Part one of our analysis looks at the possible downstream impacts on aerospace & defense ETFs. On October 7th, the[Continue Reading]

Wall Street indexes rally on bets of peak US interest rates, strong earnings Qualcomm gains as Q1 forecast tops estimates Starbucks rises on upbeat quarterly results PayPal up on profit[Continue Reading]

Novo Nordisk, Lilly see insatiable demand for weight-loss drugs Novo Nordisk and Eli Lilly both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years –[Continue Reading]

How to Invest in Companies Before They Go Public Companies used to do an initial public offering (IPO) when they were much younger, giving investors a much better chance of[Continue Reading]

BATRA, GPC, TXT, CR: The Economy Is Not So Bad The economy is not so bad, notes Mario Gabelli. He discusses market headwinds such as conflicts in the Middle East,[Continue Reading]

This Chip Stock Looks Like a Buy Ahead of Earnings Chip stocks have gotten crushed recently—and shares of ON Semiconductor are no exception. It’s cheap now, and could pop if[Continue Reading]

[Continue Reading]

Lower-Income Consumers Are Starting To Feel The Pinch The rotation of trillions from consumers to central banks has weakened the transmission mechanism of monetary policy, notes Ben Kirby. He discusses[Continue Reading]

Laffer Tengler Investments CEO on US Markets Nancy Tengler, chief executive officer and chief information officer at Laffer Tengler Investments, discusses her outlook and investment strategies on US markets. She[Continue Reading]

Wall Street Embraces AI Despite Risks of Catastrophe “One day we will give agency to the systems,” said one person at the forefront; even those who aren’t worried say concern[Continue Reading]

Gabelli Funds’ Kevin Dreyer offers his ‘underfollowed and unloved’ stock picks Kevin Dreyer, Gabelli Funds co-CIO, joins ‘Closing Bell’ to discuss opportunity plays outside of mega-cap tech. Source: https://www.cnbc.com/video/2023/10/25/gabelli-funds-kevin-dreyer-offers-his-underperformed-and-unloved-stock-picks.html[Continue Reading]

Post-Earnings Meta Rally Fails to Prop Up QQQ: Markets Wrap Nasdaq 100 notches worst slide of 2023 as bond yields climb iYen drops to weakest this year versus dollar on[Continue Reading]